-
Mashup Score: 1
Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Core Facilities & Resources - 2 year(s) ago
Scientists at the Sloan Kettering Institute have access to a variety of state-of-the-art core facilities that provide services and technology to support research.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
One thing that sets MSK apart from other institutions is our core facilities: a group of 26 state-of-the art laboratories that support our research programs and clinical trials. Learn more: https://t.co/eUcGizb5hP https://t.co/3yWo9DsDjS
-
-
Mashup Score: 5With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control - 2 year(s) ago
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In biology, getting rid of things can be just as important as making them. 🗑 Click to learn how SKI structural biologist Dr. Chris Lima & postdoc @itsrhyan are using cryo-EM to visualize NEXT, a key protein in RNA degradation, for the first time ever. https://t.co/E9EMXwHL69.
-
-
Mashup Score: 12New Imaging Technique Could Improve Cancer Screening and Diagnosis in Developing Countries and Rural Areas - 2 year(s) ago
A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Is it possible to provide cheaper & faster alternatives to PET scans, especially in underserved areas across the globe? Scientists at the #SloanKetteringInstitute think so. Dr. Jan Grimm breaks down what to know about Cerenkov imaging. #CancerResearchMonth https://t.co/U8ikbNyqkL
-
-
Mashup Score: 7
With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🐦 The pigeon. An unlikely creature to feature during #CancerResearchMonth but learn how NYC’s most famous residents are helping us better understand #CancerMetabolism. https://t.co/54wwrg3ZKj @paigearnold2 @lydfinley #CancerResearch
-
-
Mashup Score: 2
Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🐠 Zebrafish are commonly found in aquariums. But the researchers in @whitefishlab at the Sloan Kettering Institute study them to discover where cancer starts and how it spreads. Learn more about their latest research: https://t.co/LR1ONBTRp0 #CancerResearchMonth https://t.co/bgEb0pUWdd
-
-
Mashup Score: 7The Mystery of Metastasis: Can a Tumor’s Genetic Mutations Predict Whether and Where Cancer Will Spread? - 2 year(s) ago
Data from 25,000 patients is helping scientists answer this and many other important questions.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔮 Data from 25,000 patients is helping scientists answer some of the mysteries of metastasis and many other important questions. https://t.co/muGLmjTPwU #CancerMetastasis #CancerResearch #CancerResearchMonth @fsanchezvega @nikolausschultz
-
-
Mashup Score: 2
The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🧬 Think you know how DNA damage repair works? Think again. Researchers at SKI have results that overturn some conventional wisdom. https://t.co/qa1nNTBEt8 #CancerResearch #CancerResearchMonth
-
-
Mashup Score: 0
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Immunotherapy is a great help to many with cancer – but many others don’t respond to the treatment. This month, @MingLiLab and his team published a study in @NaturePortfolio that could help narrow this gap. https://t.co/1bA0ZwipC4
-
-
Mashup Score: 7
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
Source: Sloan Kettering InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨 Breaking news from #SKI researchers! A recently discovered immune cell “soldier” could help narrow the gap between people who respond to #immunotherapy and those who do not. Learn more here. @NaturePortfolio @MingLiLab https://t.co/GZkIsjAkOo
-
Watch out @officialDannyT, there’s a new MACHETE in town — a powerful technique developed at MSK's Sloan Kettering Institute to study frequent, large-scale genetic deletions in #cancer called copy number alterations. https://t.co/rsdibbo2Na https://t.co/Ka68xQqACm